drugset / Trial / NCT00625625

Lymphatic Mapping, Sentinel Lymph Node Analysis, and Blood Tests in Detecting and Predicting Early Micrometastases in Patients With Colorectal Cancer

NCT00625625

Diagnostic

Summary

RATIONALE: Diagnostic procedures, such as lymph node mapping during surgery and sentinel lymph node biopsy, may help doctors find micrometastases and predict cancer recurrence. PURPOSE: This phase II trial is studying how well lymph node mapping during surgery together with sentinel lymph node analysis and blood testing work in detecting and predicting early micrometastases in patients with colorectal cancer.

Timeline

Start
2004-03
Primary completion
2007-11
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject isosulfan blue Diagnostic / imaging agent Other

Indications